• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 92 of 100
Interior Of A Chemist'S Shop
HealthThis is what it’s like to take ‘Female Viagra’
By TIMEAugust 19, 2015
Flibanserin
Health‘Female Viagra’ drug approved by FDA
By TIMEAugust 19, 2015
Pharmaceuticals, Viagra
Health‘Female Viagra’ could get approval today
By Michal AddadyAugust 18, 2015
Production At The Merck KGaA Pharmaceutical Plant
FinanceWhy drug companies are betting big on ‘pharmerging’ countries
By Laura LorenzettiAugust 14, 2015
CVS/Caremark will no longer cover these drugs, including Viagra
HealthCVS/Caremark will no longer cover these drugs, including Viagra
By Chris MatthewsAugust 7, 2015
Pershing Square Capital Management LP Founder And Chief Executive Officer William "Bill" Ackman
FeaturesAckman’s back and Allergan — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithAugust 6, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
HealthShire offers to buy rival drugmaker Baxalta for $30 billion
By ReutersAugust 4, 2015
Brenton Saunders, David Pyott
FinanceFrom Actavis to Allergan: One pharma company’s wild dealmaking journey
By Stacy Jones, Kacy Burdette and Jen WiecznerJuly 30, 2015
Watson computer at IBM in New York City
TechIBM Watson Health now counts CVS Health as a partner
By Jonathan VanianJuly 30, 2015
Marijuana plants for sale are displayed at the medical marijuana farmers market in Los Angeles
TechMedical marijuana firm Potbotics to launch ‘virtual budtenders’
By Dan ReillyJuly 28, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
FinanceThe real reasons for the pharma merger boom
By Jen WiecznerJuly 28, 2015
The Fed, GM and a Twitter update–5 things to know today
FeaturesThe Fed, GM and a Twitter update–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 28, 2015
Inside Teva Pharmaceuticals Headquarters
Israeli drug firm Teva buys Allergan’s generics business for $40 billion
By Geoffrey SmithJuly 27, 2015
157934085
FinanceTeva in talks to buy Allergan’s generic drug business
By ReutersJuly 26, 2015
World’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
FeaturesWorld’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
By Laura LorenzettiJuly 24, 2015
1...
  • 90
  • 91
  • 92
  • 93
  • 94
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.